Neogen Chemicals announced its participation in a virtual analysts and investors group meeting scheduled for Monday, September 28, 2026. The session is set to begin at 4:00 pm (IST) and will be conducted via a group meeting format.

The company filed this intimation with the stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was signed by Unnati Kanani, Company Secretary & Compliance Officer, on September 23, 2026.

Meeting Details

The upcoming interaction is part of the Arihant Capital – Bharat Connect Conference: Rising Stars. Neogen Chemicals management will discuss the company's business overview, financial performance, and future outlook during the session.

Disclosure Guidelines

The company clarified that no unpublished price sensitive information will be shared during the meeting. Additionally, the date and list of participants remain subject to change due to exigencies involving organizers, investors, analysts, or the company itself.

Investors can access the presentation and further details through the company's official investor relations portal.

Neogen Chemicals completed its first-ever qualified institutional placement (QIP) on September 16, 2026, raising ₹5,99,99,98,015. The issue was oversubscribed 6.5x, reflecting strong demand from marquee domestic and global institutional investors.

The company allotted 26,60,753 equity shares at ₹2,255 per share. This price includes a premium of ₹2,245 over the face value of ₹10 and is above the floor price of ₹2,189.73 set on September 10, 2026.

Pricing and Regulatory Framework

The final issue price was determined in consultation with lead managers Inga Ventures Private Limited, IIFL Capital Services Limited, and Kotak Mahindra Capital Company Limited. Trilegal acted as legal counsel to the company, while JSA Advocates & Solicitors advised the lead managers.

The QIP was conducted under Chapter VI of the SEBI ICDR Regulations and Sections 42 and 62 of the Companies Act, 2013. The preliminary placement document was approved on September 10, 2026, and the final document dated September 16, 2026, was filed with BSE Limited and the National Stock Exchange of India Limited.

Allotment Details

The Board of Directors initially approved the issue on July 24, 2026, with shareholder approval via special resolution on August 21, 2026. The allotment increases paid-up equity share capital from ₹27,38,16,740 (2,73,81,674 shares) to ₹30,04,24,270 (3,00,42,427 shares).

Major allottees receiving more than 5% of the equity shares offered include:

Other significant investors include ICICI Prudential Commodities Fund, ICICI Prudential Mid Cap Fund, Mirae Asset funds, WhiteOak Capital funds, and Axis Mutual Fund schemes.

Strategic Implications

Proceeds will be utilized for repayment or pre-payment of borrowings, funding long-term working capital requirements, and general corporate purposes. This aims to reduce outstanding indebtedness, lower debt servicing costs, and improve the debt-to-equity ratio.

Dr. Harin Kanani, Managing Director, stated that the raise enabled the company to secure more equity in a single transaction than across all seven years since listing. He noted that strengthening the balance sheet enhances financial flexibility as the company transitions from capital deployment to operational execution in advanced battery materials.